Search - tctmd.com

Displaying 661 - 680 of 864

Sort: Relevancy | Date

Presentation TCT 2015

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Presentation TCT 2015

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Deepak L. Bhatt

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Presenter: William A. Gray, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Pascal Vranckx, Renato D. Lopes

October 14, 2015

Presentation TCT 2015

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Presenter: Pascal Vranckx, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Reversal Agents for Factor Xa Inhibitors

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel

October 14, 2015

Presentation TCT 2015

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

Presenter: Lisa K. Jennings, Matthew T. Roe, Pascal Vranckx

October 14, 2015

Presentation TCT 2015

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

Presenter: John P. Cheatham, Carlos Pedra, Maria Del Trigo

October 13, 2015

Presentation TCT 2015

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

Presenter: Eric A. Cohen, Truls Råmunddal, Ching-Chang Huang

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

Presentation TCT 2015

Acute DAPT Decisions: Agent Selection and Whether to Load

Presenter: George D. Dangas, Paul A. Gurbel

October 13, 2015

Presentation TCT 2015

How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

Case 2: How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Michael S. Lee

October 12, 2015

Presentation TCT 2015

Case 2: A Patient With Cardiac Arrest and ST-Segment Elevation

Presenter: Paul A. Gurbel, Daniel I. Simon, Michael S. Lee

October 12, 2015

Advertisement

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Reversal Agents for Factor Xa Inhibitors

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Acute DAPT Decisions: Agent Selection and Whether to Load

How Did We Manage This Patient?

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Case 2: How Did We Manage This Patient?

Case 2: A Patient With Cardiac Arrest and ST-Segment Elevation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content